0      0


2935 - Safety and Efficacy of Immunomodulatory Therapy Using Antithymocyte Globulin and Pegfilgrastim in Japanese Patients with Type 1 Diabetes—A Pilot Randomized Clinical Trial


‐ Jun 25, 2023 2:30pm


Speaker(s):

You must be logged in and own this session in order to post comments.